Replies to post #99026 on Biotech Values

[DewDiligence]

Time’s up on the quiz in #msg-52402548. I thought this was one of the easiest quizzes I’ve posted on this board, but evidently it wasn’t.

Q: The Reuters newswire in #msg-52402466 has a major mistake—what is it?

A: Reuters forgot about Sustiva, the blockbuster non-nuke from BMY that is both a standalone drug and a component of Atripla.